Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

CIS

1 clinical trial

1 product

Clinical trial
A Phase 4, Multi-center, Open Label Trial to Evaluate Efficacy of Retreatment With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose
Status: Not yet recruiting, Estimated PCD: 2026-07-31
Product
Nadofaragene Firadenovec